These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19826562)

  • 21. SIR2: a potential target for calorie restriction mimetics.
    Chen D; Guarente L
    Trends Mol Med; 2007 Feb; 13(2):64-71. PubMed ID: 17207661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function.
    Kitada M; Ogura Y; Monno I; Koya D
    Front Endocrinol (Lausanne); 2019; 10():187. PubMed ID: 30972029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis.
    Sosnowska B; Mazidi M; Penson P; Gluba-Brzózka A; Rysz J; Banach M
    Atherosclerosis; 2017 Oct; 265():275-282. PubMed ID: 28870631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirtfoods: New Concept Foods, Functions, and Mechanisms.
    Akan OD; Qin D; Guo T; Lin Q; Luo F
    Foods; 2022 Sep; 11(19):. PubMed ID: 36230032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Will Sirtuins Be Promising Therapeutic Targets for TBI and Associated Neurodegenerative Diseases?
    Yang Q; Zhou Y; Sun Y; Luo Y; Shen Y; Shao A
    Front Neurosci; 2020; 14():791. PubMed ID: 32848564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage.
    Wang C; Chen L; Hou X; Li Z; Kabra N; Ma Y; Nemoto S; Finkel T; Gu W; Cress WD; Chen J
    Nat Cell Biol; 2006 Sep; 8(9):1025-31. PubMed ID: 16892051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.
    Howitz KT; Bitterman KJ; Cohen HY; Lamming DW; Lavu S; Wood JG; Zipkin RE; Chung P; Kisielewski A; Zhang LL; Scherer B; Sinclair DA
    Nature; 2003 Sep; 425(6954):191-6. PubMed ID: 12939617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The sirtuin family in health and disease.
    Wu QJ; Zhang TN; Chen HH; Yu XF; Lv JL; Liu YY; Liu YS; Zheng G; Zhao JQ; Wei YF; Guo JY; Liu FH; Chang Q; Zhang YX; Liu CG; Zhao YH
    Signal Transduct Target Ther; 2022 Dec; 7(1):402. PubMed ID: 36581622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress.
    Kobayashi Y; Furukawa-Hibi Y; Chen C; Horio Y; Isobe K; Ikeda K; Motoyama N
    Int J Mol Med; 2005 Aug; 16(2):237-43. PubMed ID: 16012755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sirtuin modulators: an updated patent review (2012 - 2014).
    Mellini P; Valente S; Mai A
    Expert Opin Ther Pat; 2015 Jan; 25(1):5-15. PubMed ID: 25435179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirtuins and disease: the road ahead.
    Carafa V; Nebbioso A; Altucci L
    Front Pharmacol; 2012; 3():4. PubMed ID: 22319497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region-specific changes in the immunoreactivity of SIRT1 expression in the central nervous system of SOD1(G93A) transgenic mice as an in vivo model of amyotrophic lateral sclerosis.
    Lee JC; Shin JH; Park BW; Kim GS; Kim JC; Kang KS; Cha CI
    Brain Res; 2012 Jan; 1433():20-8. PubMed ID: 22137654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirtuin-independent effects of nicotinamide on lifespan extension from calorie restriction in yeast.
    Tsuchiya M; Dang N; Kerr EO; Hu D; Steffen KK; Oakes JA; Kennedy BK; Kaeberlein M
    Aging Cell; 2006 Dec; 5(6):505-14. PubMed ID: 17129213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirtuin functions in health and disease.
    Yamamoto H; Schoonjans K; Auwerx J
    Mol Endocrinol; 2007 Aug; 21(8):1745-55. PubMed ID: 17456799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
    Gan L
    Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2.5 Å crystal structure of the SIRT1 catalytic domain bound to nicotinamide adenine dinucleotide (NAD+) and an indole (EX527 analogue) reveals a novel mechanism of histone deacetylase inhibition.
    Zhao X; Allison D; Condon B; Zhang F; Gheyi T; Zhang A; Ashok S; Russell M; MacEwan I; Qian Y; Jamison JA; Luz JG
    J Med Chem; 2013 Feb; 56(3):963-9. PubMed ID: 23311358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
    Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
    Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HST2 mediates SIR2-independent life-span extension by calorie restriction.
    Lamming DW; Latorre-Esteves M; Medvedik O; Wong SN; Tsang FA; Wang C; Lin SJ; Sinclair DA
    Science; 2005 Sep; 309(5742):1861-4. PubMed ID: 16051752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular and molecular biology of sirtuins in cardiovascular disease.
    Liu YP; Wen R; Liu CF; Zhang TN; Yang N
    Biomed Pharmacother; 2023 Aug; 164():114931. PubMed ID: 37263163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sirtuins in mammals: insights into their biological function.
    Michan S; Sinclair D
    Biochem J; 2007 May; 404(1):1-13. PubMed ID: 17447894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.